Find a Clinical Trial

Filter By:

Title	Investigator
2-[¹⁸F]-Deoxy-D-Glucose (FDG) and [¹⁸F] Dihydro-Testosterone PET Imaging in Patients with Progressive Prostate Cancer [Protocol 00-095]	Morris, Michael, MD
A Clinical Trial for Patients with Standard Risk B-Precursor Acute Lymphoblastic Leukemia [Protocol 06-039]	Shukla, Neerav, MD
A Genotype-Phenotype Urothelial Cancer Study [Protocol 09-025]	Bajorin, Dean, MD
A Global Assessment of Medical, Emotional, and Reproductive Concerns in Survivors of Gestational Trophoblastic Disease [Protocol 08-040]	Aghajanian, Carol, MD
A Multicenter Phase I Study of Deforolimus (AP23573) in Pediatric Patients with Advanced Solid Tumors [Protocol 08-110]	Pratilas, Christine, MD
A Multicenter Treatment Protocol for Compassionate Use of Ipilimumab Monotherapy in Patients with Unresectable Stage III or Stage IV Melanoma [Protocol 07-156]	Wolchok, Jedd, MD, PhD
A Multicenter Trial Evaluating Computed Tomography and Serum CA-125 for the Management of Newly Diagnosed Ovarian Cancer [Protocol 01-048]	Chi, Dennis, MD
A Non-Myeloablative Conditioning Regimen with Peri-Transplant Rituximab and Stem Cell Transplantation in Patients with B-cell Non-Hodgkin's Lymphoma [Protocol 06-150]	Castro-Malaspina, Hugo, MD
A Non-Myeloablative Conditioning Regimen with Peri-Transplant Rituximab and the Transplantation of Unrelated Donor Umbilical Cord Blood in Patients with B cell Lymphoid Malignancies [Protocol 06-066]	Barker, Juliet, MBBS
A Pharmacodynamic Assessment of the Effect of BIIB021 (CNF2024 or CF1983) in Patients with Gastrointestinal Stromal Tumors (GIST) Refractory to, Intolerant of, or Not Candidates for Imatinib and Sunitinib [Protocol 07-173]	Schwartz, Gary, MD
A Phase I Combination Trial of SGN-33 (Anti-huCD33 mAb; HuM195; Lintuzumab) and Lenalidomide (Revlimid^®) in Patients with Myelodysplastic Syndromes [Protocol 07-143]	Jurcic, Joseph, MD
A Phase I Dose Escalation Study Using Ultra-Hypofractionated, Image-Guided, Intensity-Modulated Radiotherapy in Prostate Cancer [Protocol 09-035]	Cox, Brett, MD
A Phase I Study of 3F8 Antibody plus Granulocyte-Macrophage Colony-Stimulating Factor in High-Risk Neuroblastoma [Protocol 05-015]	Kushner, Brian, MD
A Phase I Study of AGS-16M18 in Patients with Advanced Renal Cell Carcinoma [Protocol 08-086]	Kroog, Glenn, MD
A Phase I Study of AGS-8M4 Given as Monotherapy in Patients with Advanced Ovarian Cancer [Protocol 08-111]	Sabbatini, Paul, MD
A Phase I Study of AZD7762 plus Irinotecan in Patients with Advanced Solid Malignancies [Protocol 07-057]	Tse, Archie, MD
A Phase I Study of CNF2024 Alone in Patients with HER2-Negative Advanced Breast Cancer or with Trastuzumab in Patients with HER2-Positive Advanced Breast Cancer [Protocol 07-123]	Modi, Shanu, MD
A Phase I Study of Clofarabine Plus Topotecan, Vinorelbine, Thiotepa, and Dexamethasone in Pediatric Patients with Relapsed or Refractory Acute Leukemia [Protocol 07-012]	Steinherz, Peter, MD
A Phase I Study of Genetically Modified T Cells to Treat Recurrent or Refractory Chronic Lymphocytic Leukemia [Protocol 06-138]	Brentjens, Renier, MD, PhD
A Phase I Study of HER2/neu DNA Immunization for Patients with Metastatic or High-Risk Breast Cancer [Protocol 04-101]	Gilewski, Teresa, MD
A Phase I Study of High-Dose Single Fraction Image-Guided Radiotherapy for Metastatic Lesions to Soft Tissue, Lymph Nodes, or Bone [Protocol 06-101]	Zelefsky, Michael, MD
A Phase I Study of Intrathecal Radioimmunotherapy Using ¹³¹I-8H9 for Central Nervous System/Leptomeningeal Cancers [Protocol 03-133]	Kramer, Kim, MD
A Phase I Study of KW-2450 in Patients with Previously Treated Advanced Solid Tumors [Protocol 09-027]	Schwartz, Gary, MD
A Phase I Study of MDX1411 in Patients with Advanced or Recurrent Clear Cell Renal Cell Carcinoma [Protocol 08-029]	Kroog, Glenn, MD
A Phase I Study of NY-ESO-1 Overlapping Peptides with or without Montanide Vaccination in Patients with Ovarian, Fallopian Tube, or Primary Peritoneal Cancer in Second or Third Remission [Protocol 07-152]	Sabbatini, Paul, MD
A Phase I Study of PF-00477736 with Gemcitabine in Patients with Advanced Solid Malignancies [Protocol 07-017]	Tse, Archie, MD
A Phase I Study of PLX4032 in Patients with Metastatic Melanoma [Protocol 06-148]	Chapman, Paul, MD
A Phase I Study of Panitumumab in Children with Solid Tumors [Protocol 08-020]	Meyers, Paul, MD
A Phase I Study of Post-Operative Radiation Therapy plus RAD001 (Everolimus) and Cisplatin for Patients with Head and Neck Cancer [Protocol 08-138]	Fury, Matthew, MD, PhD
A Phase I Study of Pralatrexate with Vitamin B12 and Folic Acid Supplementation in Patients with Relapsed or Refractory Cutaneous T-cell Lymphoma [Protocol 07-146]	Horwitz, Steven, MD
A Phase I Study of R1507 in Children and Adolescents with Advanced Solid Tumors [Protocol 07-142]	Trippett, Tanya, MD
A Phase I Study of R7112 in People with Advanced Cancers (Except Leukemia) [Protocol 08-002]	Maki, Robert, MD
A Phase I Study of Sorafenib plus Isolated Limb Infusion of Melphalan in Patients with Locally Advanced Malignant Melanoma [Protocol 08-052]	Brady, Mary, MD
A Phase I Study of Vaccine Replicon Particles (VRP) Expressing Prostate-Specific Membrane Antigen (PSMA) in Patients with Prostate Cancer [Protocol 08-028]	Slovin, Susan, MD, PhD
A Phase I Study of WT1-Sensitized T cells for Residual or Relapsed Leukemia after Allogeneic Hematopoietic Progenitor Cell Transplantation [Protocol 07-055]	O'Reilly, Richard, MD
A Phase I Study of WT1-Specific T Cells for the Treatment of Patients with Advanced Ovarian, Primary Peritoneal, and Fallopian Tube Cancers [Protocol 06-155]	Aghajanian, Carol, MD
A Phase I Study of Weekly Low-Dose Cisplatin Plus Escalating Doses of Oral RAD001 (Everolimus) for Patients with Advanced Solid Tumors [Protocol 06-129]	Fury, Matthew, MD, PhD
A Phase I Study of XL281 in Patients with Advanced Solid Tumors [Protocol 07-020]	Schwartz, Gary, MD
A Phase I Study of XL765 in Combination with Temozolomide in Patients with Malignant Gliomas [Protocol 08-057]	Omuro, Antonio, MD
A Phase I Study of Yttrium-90 Attached to Chimeric Monoclonal Antibody CG250 in Patients with Advanced Renal Cancer [Protocol 05-031]	Larson, Steven, MD
A Phase I Study of the Monoclonal Antibody HGS-ETR2 (Lexatumumab) in Patients with Refractory Pediatric Solid Tumors [Protocol 07-071]	Meyers, Paul, MD
A Phase I Trial of Doxorubicin and Flavopiridol in the Treatment of Metastatic Sarcoma [Protocol 04-075]	D'Adamo, David, MD
A Phase I Trial of Sequential Paclitaxel/Ifosfamide and Dose-Intensive Paclitaxel, Carboplatin, and Dose-Escalated Ifosfamide with Stem Cell Support in Cisplatin- Resistant Germ Cell Tumor Patients [Protocol 06-077]	Feldman, Darren, MD
A Phase I Trial of a Trivalent Vaccine with Escalating Doses of the Immunological Adjuvant OPT-821 Plus Oral ß-Glucan for High-Risk Neuroblastoma [Protocol 05-075]	Kushner, Brian, MD
A Phase I-II Study of Dasatinib plus Paclitaxel in Patients with Metastatic Breast Cancer [Protocol 08-122]	Fornier, Monica, MD
A Phase I-II Study of Pentostatin, Cyclophosphamide, Rituximab, and Mitoxantrone in Previously Treated Patients with Chronic Lymphocytic Leukemia and Other Low Grade B-Cell Cancers [Protocol 05-077]	Lamanna, Nicole, MD
A Phase I/II Study of BMS-753493 in Patients with Advanced Cancer [Protocol 08-032]	Konner, Jason, MD
A Phase I/II Study of Bortezomib with Rituximab, Cyclophosphamide, and Prednisone in Patients with Relapsed/Refractory Indolent B-cell Lymphoproliferative Disorders and Mantle Cell Lymphoma (MCL) [Protocol 05-103]	Gerecitano, John, MD, PhD
A Phase I/II Study of Cetuximab and Erlotinib in Patients with Lung Adenocarcinoma Who Have Developed Resistance to Erlotinib Alone [Protocol 08-055]	Riely, Gregory, MD, PhD
A Phase I/II Study of Cisplatin, Etoposide, and Sunitinib for Untreated Advanced Small Cell Lung Cancer [Protocol 07-106]	Krug, Lee, MD
A Phase I/II Study of Clofarabine in Combination with Etoposide and Cyclophosphamide in Pediatric Patients with Refractory or Relapsed Acute Leukemia [Protocol 07-039]	Steinherz, Peter, MD
A Phase I/II Study of Clofarabine in Patients with Relapsed T-cell and NK-Cell Lymphomas [Protocol 06-065]	Horwitz, Steven, MD
A Phase I/II Study of Decitabine and All-Trans Retinoic Acid (Tretinoin) for Patients with Myelodysplastic Syndromes [Protocol 06-054]	Klimek, Virginia, MD
A Phase I/II Study of HE3235 in Patients with Prostate Cancer [Protocol 08-090]	Morris, Michael, MD
A Phase I/II Study of ON 01910.Na in Patients with Intermediate-1, Intermediate-2 or High-Risk Myelodysplastic Syndrome [Protocol 09-006]	Klimek, Virginia, MD
A Phase I/II Study of Obatoclax Mesylate (GX15-070MS) Plus Topotecan in Patients with Relapsed Small Cell Lung Carcinoma [Protocol 07-082]	Krug, Lee, MD
A Phase I/II Study of SB-743921 in Patients with Non-Hodgkin's Lymphoma [Protocol 07-083]	Gerecitano, John, MD, PhD
A Phase I/II Study of the Tor Kinase Inhibitor AZD8055 in Patients with Advanced Solid Tumors, Lymphomas, or Endometrial Carcinoma [Protocol 08-093]	Aghajanian, Carol, MD
A Phase I/II Study of the Toxic and Therapeutic Effects of T Cells in the Treatment of Epstein Barr Virus-Associated Lymphoproliferative Disorders [Protocol 95-024]	O'Reilly, Richard, MD
A Phase I/II Trial of Clofarabine, Melphalan, and Thiotepa Followed by an Allogeneic Stem Cell Transplant for the Treatment of High-Risk and/or Advanced Hematologic Malignancies [Protocol 06-125]	Boulad, Farid, MD
A Phase I/II Trial of PTC299 in Patients with HIV-Related Kaposi's Sarcoma [Protocol 08-064]	Krown, Susan, MD
A Phase I/II Trial of Vorinostat in Combination with Cyclophosphamide, Etoposide, Prednisone, and Rituximab for Elderly Patients with Relapsed Diffuse Large B-Cell Lymphoma [Protocol 08-045]	Straus, David, MD
A Phase I/IIA Study of Pralatrexate and Gemcitabine with Vitamin B12 and Folic Acid Supplementation in Patients with Relapsed or Refractory Lymphoma [Protocol 07-062]	Horwitz, Steven, MD
A Phase I/IIa Study Evaluating ABT-263 in Patients with Relapsed or Refractory Lymphoid Malignancies [Protocol 07-048]	Gerecitano, John, MD, PhD
A Phase IB Study Evaluating the Safety of BSI-201 in Combination with Chemotherapeutic Regimens in Patients with Advanced Solid Tumors [Protocol 08-048]	Bell-McGuinn, Katherine, MD, PhD
A Phase II Clinical Trial of Bortezomib, Pegylated Liposomal Doxorubicin (DOXIL^®), and Dexamethasone Followed by Thalidomide and Dexamethasone with or without Bortezomib in Patients with High-Risk or Resistant Multiple Myeloma [Protocol 06-067]	Landau, Heather, MD
A Phase II Clinical and Translational Study of MK-0646 in Patients with Metastatic Neuroendocrine Tumors [Protocol 07-162]	Saltz, Leonard, MD
A Phase II Multicenter Trial of Myeloablative Double Unit Umbilical Cord Blood Transplantation in Adults with Hematological Cancers [Protocol 07-072]	Barker, Juliet, MBBS
A Phase II Pilot Trial of Hematopoietic Stem Cell Transplantation with Total Body Irradiation, Cyclophosphamide & Fludarabine to Treat Patients with Fanconi Anemia Lacking a Genotypically Identical Donor [Protocol 01-062]	Boulad, Farid, MD
A Phase II Randomized Controlled Trial of Acupuncture for Reduction of Post-Colectomy Ileus [Protocol 06-145]	Deng, Gary, MD, PhD
A Phase II Study Comparing Two Different Doses of Biweekly Cetuximab for Platinum-Refractory Cancers of the Head and Neck [Protocol 08-039]	Fury, Matthew, MD, PhD
A Phase II Study of AZD0530 for Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma [Protocol 06-074]	Fury, Matthew, MD, PhD
A Phase II Study of AZD0530 in Hormone-Receptor-Negative Metastatic Breast Cancer or Unresectable Locally Advanced Breast Cancer [Protocol 07-112]	Hudis, Clifford, MD
A Phase II Study of AZD6244 in Women with Recurrent Low-Grade Serous Ovarian Cancer [Protocol 09-007]	Leitao, Mario, MD
A Phase II Study of Anti-GD2 Antibody 3F8 and GM-CSF for High-Risk Neuroblastoma [Protocol 03-077]	Kushner, Brian, MD
A Phase II Study of BIBW 2992 in Non-Small Cell Lung Cancer Patients with EGFR-Activating Mutations [Protocol 07-180]	Miller, Vincent, MD
A Phase II Study of Bendamustine HCl in Relapsed and Primary Refractory Hodgkin's Lymphoma [Protocol 08-041]	Moskowitz, Craig, MD
A Phase II Study of Bevacizumab, Temozolomide and Hypofractionated Radiotherapy for Patients with Newly Diagnosed Glioblastoma [Protocol 08-126]	Omuro, Antonio, MD
A Phase II Study of Bicalutamide for the Treatment of Androgen-Receptor-Positive, Estrogen- and Progesterone-Receptor-Negative Metastatic Breast Cancer [Protocol 07-022]	Hudis, Clifford, MD
A Phase II Study of Carboplatin and Gemcitabine with or without Bevacizumab in Patients with Platinum-Sensitive Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer [Protocol 07-078]	Aghajanian, Carol, MD
A Phase II Study of Cetuximab for Women with Persistent or Recurrent Squamous or Nonsquamous Cell Carcinoma of the Cervix [Protocol 07-148]	Leitao, Mario, MD
A Phase II Study of Conformal Radiotherapy in Patients with Low-Grade Gliomas [Protocol 07-049]	Dunkel, Ira, MD
A Phase II Study of E7389 in Recurrent Epithelial Ovarian, Fallopian Tube, or Peritoneal Cancer [Protocol 06-027]	Hensley, Martee, MD
A Phase II Study of Erlotinib and Chemotherapy for Operable Stage IB-IIIA Non-Small Cell Lung Cancer Patients Who Are Nonsmokers or Light Smokers [Protocol 07-103]	Rizvi, Naiyer, MD
A Phase II Study of Ertumaxomab in Patients with HER-2-Positive Metastatic Breast Cancer Progressing After Trastuzumab Treatment [Protocol 07-155]	Modi, Shanu, MD
A Phase II Study of Everolimus (RAD001) in Metastatic Transitional Cell Carcinoma of the Urothelium [Protocol 08-123]	Milowsky, Matthew, MD
A Phase II Study of FOLFOX with and without CT-011 in Patients with Colorectal Cancer Previously Untreated for Metastatic Disease [Protocol 09-022]	Segal, Neil, MD, PhD
A Phase II Study of Flavopiridol Plus Oxaliplatin with or without 5-FU and Leucovorin for Relapsed or Refractory Germ-Cell Tumors [Protocol 09-034]	Feldman, Darren, MD
A Phase II Study of Focal Cryoablation in Low-Risk Prostate Cancer [Protocol 08-118]	Eastham, James, MD
A Phase II Study of GM-CSF (Sargramostim) and Rituximab Following Autologous Transplantation for Relapsed Follicular Lymphoma [Protocol 07-085]	Moskowitz, Craig, MD
A Phase II Study of Gemcitabine, Cisplatin, and Sunitinib as Chemotherapy Before Surgery in Patients with Muscle-Invasive Bladder Cancer [Protocol 08-159]	Bajorin, Dean, MD
A Phase II Study of Hepatic Arterial Infusion with Floxuridine and Dexamethasone in Combination with Intravenous Bevacizumab in Patients with Unresectable Primary Liver Cancer [Protocol 06-114]	Jarnagin, William, MD
A Phase II Study of IMC-A12 or IMC-1121B Plus Mitoxantrone and Prednisone in Metastatic Androgen-Independent Prostate Cancer Following Disease Progression on Docetaxel-Based Chemotherapy [Protocol 08-102]	Rathkopf, Dana, MD, PhD
A Phase II Study of Imatinib in Patients with Inoperable Stage III or IV Melanoma with Alterations in the C-KIT Protein [Protocol 07-014]	Carvajal, Richard, MD
A Phase II Study of Intrathecal I¹³¹-3F8 in Patients with GD2-Expressing Central Nervous System and Leptomeningeal Neoplasms [Protocol 05-122]	Kramer, Kim, MD
A Phase II Study of Massage for the Treatment of Pain in Cancer [Protocol 03-046]	Cassileth, Barrie, PhD
A Phase II Study of Melphalan with Stem Cell Transplant and Adjuvant Bortezomib and Dexamethasone for Recently Diagnosed Untreated Systemic Light-Chain Amyloidosis [Protocol 07-006]	Landau, Heather, MD
A Phase II Study of Neoadjuvant Gemcitabine and Oxaliplatin in Patients with Potentially Resectable Previously Untreated Pancreatic Adenocarcinoma [Protocol 07-113]	O'Reilly, Eileen, MD
A Phase II Study of Paclitaxel, Carboplatin, and BSI-201 for the Treatment of Advanced, Persistent, or Recurrent Uterine Carcinosarcoma [Protocol 08-151]	Aghajanian, Carol, MD
A Phase II Study of Pemetrexed in Children with Recurrent Malignancies [Protocol 07-179]	Trippett, Tanya, MD
A Phase II Study of Pentostatin with Cyclophosphamide and Rituximab for Previously Untreated Patients with Chronic Lymphocytic Leukemia [Protocol 05-051]	Weiss, Mark, MD
A Phase II Study of Pre-Operative Chemotherapy Plus Bevacizumab with Early Salvage Therapy in Patients with Locally Advanced Resectable Gastric and Gastroesophageal Junction Adenocarcinoma [Protocol 08-081]	Shah, Manish, MD
A Phase II Study of Radiotherapy (IMRT) and Cisplatin Plus Bevacizumab for Patients with Locally Advanced Head and Neck Cancer [Protocol 06-130]	Pfister, David, MD
A Phase II Study of Rituximab, Methotrexate, Procarbazine and Vincristine Followed by High-Dose Chemotherapy with Autologous Stem Cell Rescue in Newly Diagnosed Primary CNS Lymphoma [Protocol 04-129]	Omuro, Antonio, MD
A Phase II Study of Romidepsin in Progressive or Relapsed Peripheral T-Cell Lymphoma Following Prior Systemic Therapy [Protocol 07-095]	Horwitz, Steven, MD
A Phase II Study of SGN-35 to Treat Patients with Relapsed or Refractory Hodgkin Lymphoma [Protocol 09-020]	Moskowitz, Craig, MD
A Phase II Study of Sho-saiko-to in Patients with Chronic Hepatitis C Who Cannot Use Interferon [Protocol 02-073]	Deng, Gary, MD, PhD
A Phase II Study of TLN-4601 in Patients with Glioblastoma Multiforme [Protocol 08-160]	Omuro, Antonio, MD
A Phase II Study of Temozolomide for Relapsed Sensitive or Refractory Small Cell Lung Cancer [Protocol 08-065]	Pietanza, M. Catherine, MD
A Phase II Study of XL880 in Patients with Poorly Differentiated Metastatic Gastric Cancer [Protocol 07-138]	Jhawer, Minaxi, MD
A Phase II Study of the Biologic Effect of Levonorgestrel on the Ovarian Epithelium in Women at High Risk for Ovarian Cancer [Protocol 08-150]	Kauff, Noah, MD
A Phase II Study to Evaluate Tumor Response to Ipilimumab (BMS-734016) in Patients with Melanoma Brain Metastases [Protocol 08-130]	Wolchok, Jedd, MD, PhD
A Phase II Trial of AZD6244 in Patients with V600E BRAF-Mutated Melanomas [Protocol 09-003]	Chapman, Paul, MD
A Phase II Trial of Cetuximab plus Cisplatin and Irinotecan in Patients with Irinotecan- and Cisplatin-Refractory Metastatic Esophageal and Gastric Cancer [Protocol 06-095]	Ilson, David, MD
A Phase II Trial of Continuous Low-Dose Temozolomide for Patients with Recurrent Malignant Glioma [Protocol 07-064]	Omuro, Antonio, MD
A Phase II Trial of Dasatinib in Patients with Lung Adenocarcinoma with Acquired Resistance to Erlotinib or Gefitinib [Protocol 06-143]	Miller, Vincent, MD
A Phase II Trial of Doxorubicin, Rituximab, Cyclophosphamide, Vincristine, and Prednisone (DR-COP) in Patients with Newly Diagnosed AIDS-Associated B-Cell Non-Hodgkin's Lymphoma [Protocol 07-084]	Noy, Ariela, MD
A Phase II Trial of Erlotinib in Patients with Resected, Early-Stage Non-Small Cell Lung Cancer (NSCLC) with Epidermal Growth Factor Receptor Mutations [Protocol 08-152]	Azzoli, Christopher, MD
A Phase II Trial of Exogenous Testosterone Plus Dutasteride for the Treatment of Castrate Metastatic Prostate Cancer [Protocol 09-008]	Morris, Michael, MD
A Phase II Trial of Gemcitabine and Cisplatin plus Sorafenib in Chemotherapy-naïve Patients with Locally Advanced or Metastatic Urothelial Carcinoma [Protocol 07-168]	Milowsky, Matthew, MD
A Phase II Trial of Gemcitabine, Carboplatin, and Bevacizumab in Chemotherapy-naïve Patients with Advanced/Metastatic Urothelial Carcinoma [Protocol 06-006]	Bajorin, Dean, MD
A Phase II Trial of Gemcitabine, Carboplatin, and Cetuximab with or without IMC-A12 In Chemotherapy-Naïve Patients with Advanced Non- Small Cell Lung Cancer [Protocol 08-154]	Rizvi, Naiyer, MD
A Phase II Trial of HLA Haploidentical Natural Killer Cell Infusion for Treatment of Relapsed or Persistent Leukemia Following Allogeneic Hematopoietic Stem Cell Transplant [Protocol 07-035]	Hsu, Katharine, MD, PhD
A Phase II Trial of Intensive Chemotherapy & Autotransplantation in Patients with Newly Diagnosed Anaplastic Oligodendroglioma [Protocol 02-089]	Omuro, Antonio, MD
A Phase II Trial of Intravenous Myeloablative Chemotherapy Followed by an Allogeneic Hematopoietic Stem Cell Transplant from a Matched Relative to Treat High-Risk Ewing's Sarcoma Family Tumors [Protocol 05-059]	Prockop, Susan, MD
A Phase II Trial of Irinotecan plus Carboplatin, and Irinotecan Maintenance Therapy Integrated into the Upfront Therapy of Newly Diagnosed Patients with Intermediate- and High-Risk Rhabdomyosarcoma [Protocol 03-099]	Wexler, Leonard, MD
A Phase II Trial of Irinotecan, Cisplatin, Bevacizumab, and Concurrent Radiotherapy in Locally Advanced Esophageal Adenocarcinoma [Protocol 06-013]	Ilson, David, MD
A Phase II Trial of Liposomal Doxorubicin (Doxil^®) Followed by Bexarotene (Targretin^®) in Advanced Cutaneous T-Cell Lymphoma [Protocol 05-098]	Straus, David, MD
A Phase II Trial of Paclitaxel, Pemetrexed, and Bevacizumab in Patients with Untreated, Advanced Non-Small Cell Lung Cancer Using Web-Based Data Collection, Patient Self-Reporting of Adverse Effects, and Automated Response Assessment [Protocol 08-109]	Pietanza, M. Catherine, MD
A Phase II Trial of Patupilone in Patients with Brain Metastases from Breast Cancer [Protocol 07-036]	Seidman, Andrew, MD
A Phase II Trial of R1507 for People with Recurrent Sarcoma [Protocol 07-166]	Maki, Robert, MD
A Phase II Trial of Risk-Adapted High-Dose Chemoradiotherapy and Autologous Stem Cell Transplantation for Patients with Relapsed and Primary Refractory Hodgkin's Lymphoma [Protocol 04-047]	Moskowitz, Craig, MD
A Phase II Trial of Sorafenib and Dacarbazine in Soft-Tissue Sarcoma [Protocol 08-068]	D'Adamo, David, MD
A Phase II Trial of Sunitinib (Sutent^®) in Patients with Recurrent or Inoperable Meningioma [Protocol 07-135]	Abrey, Lauren, MD
A Phase II Trial of Temozolomide and Radiotherapy Followed by Temozolomide and Maintenance Cis-retinoic Acid for Patients with Newly Diagnosed Gliomas [Protocol 05-079]	Lassman, Andrew, MD
A Phase II Trial of Temsirolimus or the Combination of Hormonal Therapy Plus Temsirolimus in Women with Advanced, Persistent, or Recurrent Endometrial Carcinoma [Protocol 09-019]	Aghajanian, Carol, MD
A Phase III Study Assessing Carboplatin and/or Isotretinoin plus Radiation in Patients with Supratentorial Primitive Neuroectodermal Tumor or High-Risk Medulloblastoma [Protocol 07-174]	Gilheeney, Stephen, MD
A Phase III Study of ABVD with or without Rituximab for Patients with Advanced-Stage Classical Hodgkin Lymphoma with Poor-Risk Features [Protocol 08-063]	Portlock, Carol, MD
A Phase III Study of Abiraterone Acetate Plus Prednisone in Men with Metastatic Castration-Resistant Prostate Cancer [Protocol 09-032]	Rathkopf, Dana, MD, PhD
A Phase III Study of Abiraterone Acetate plus Prednisone in Patients with Metastatic Castration-Resistant Prostate Cancer that Persists Despite Docetaxel-Based Chemotherapy [Protocol 08-037]	Scher, Howard, MD
A Phase III Study of Adjuvant Sunitinib versus Placebo in Patients with High-Risk Renal Cell Carcinoma [Protocol 07-086]	Motzer, Robert, MD
A Phase III Study of Androgen Deprivation with Leuprolide with or without Docetaxel for Clinically Asymptomatic Prostate Cancer Patients with a Rising PSA Following Surgery [Protocol 07-101]	Morris, Michael, MD
A Phase III Study of Axitinib versus Sorafenib as Second-line Therapy for Metastatic Renal Cell Cancer: the AXIS trial [Protocol 08-059]	Motzer, Robert, MD
A Phase III Study of Carboplatin and Paclitaxel Alone or with Bevacizumab Followed by Bevacizumab and Secondary Cytoreductive Surgery in Platinum-Sensitive, Recurrent Ovarian, Primary Peritoneal, and Fallopian Tube Cancer [Protocol 08-074]	Leitao, Mario, MD
A Phase III Study of Conventional Whole Breast Irradiation Versus Partial Breast Irradiation for Women with Early-Stage Breast Cancer [Protocol 05-068]	McCormick, Beryl, MD
A Phase III Study of Early Versus Standard Zoledronic Acid to Prevent Bone Problems in Men with Prostate Cancer that Has Spread to the Bone [Protocol 06-091]	Morris, Michael, MD
A Phase III Study of Fulvestrant with or without Lapatinib (Tykerb^®) for Postmenopausal Women with Hormone-Receptor-Positive Advanced Breast Cancer [Protocol 07-122]	Lake, Diana, MD
A Phase III Study of Intensive Induction Chemotherapy with or without Methotrexate Followed by Consolidation Therapy with Stem Cell Rescue in Young Children Newly Diagnosed with Supratentorial PNET or High-Risk Medulloblastoma [Protocol 07-170]	Gilheeney, Stephen, MD
A Phase III Study of Ipilimumab versus Placebo after Complete Resection of High-Risk Stage III Melanoma [Protocol 08-085]	Wolchok, Jedd, MD, PhD
A Phase III Study of Lanreotide Injections in Patients with Neuroendocrine Tumors [Protocol 08-133]	Reidy-Lagunes, Diane, MD
A Phase III Study of Maintenance Therapy with CC-5013 or Placebo After Autologous Stem Cell Transplantation for Multiple Myeloma [Protocol 05-080]	Hassoun, Hani, MD
A Phase III Study of Multimodality Therapy for Extra-ocular Retinoblastoma [Protocol 08-072]	Dunkel, Ira, MD
A Phase III Study of Neo-Adjuvant Docetaxel and Androgen Deprivation versus Immediate Radical Prostatectomy in Patients with High-Risk, Clinically Localized Prostate Cancer [Protocol 07-041]	Eastham, James, MD
A Phase III Trial of Acupuncture for the Treatment of Chronic Post-Chemotherapy Fatigue [Protocol 04-081]	Deng, Gary, MD, PhD
A Phase III Trial of Cyclophosphamide and Doxorubicin Versus Paclitaxel as Adjuvant Therapy for Women with Node-Negative Breast Cancer [Protocol 04-042]	Lake, Diana, MD
A Phase III Trial of Doxorubicin and Cyclophosphamide Followed by Paclitaxel with or without Bevacizumab in Patients with Lymph-Node-Positive and High-Risk Lymph-Node-Negative Breast Cancer [Protocol 08-035]	Dang, Chau, MD
A Phase III Trial of Hormonal Therapy Alone or with Bevacizumab in Women with Locally Advanced or Metastatic Hormone-Receptor-Positive Breast Cancer [Protocol 08-094]	Dickler, Maura, MD
A Phase III Trial of Oral Suberoylanilide Hydroxamic Acid (L-001079038) in Patients With Advanced Malignant Pleural Mesothelioma Previously Treated With Systemic Chemotherapy [Protocol 05-095]	Krug, Lee, MD
A Phase IIb Study of Gemcitabine with or without Sorafenib in Women with Locally Advanced or Metastatic Breast Cancer That Has Progressed During or After Bevacizumab Therapy [Protocol 07-131]	Hudis, Clifford, MD
A Phase Ia/Ib Study of a DNA Vaccine in Patients with Stage IIB-IV Malignant Melanoma [Protocol 07-003]	Wolchok, Jedd, MD, PhD
A Phase Ib Study of MDX-1106 in Patients with Selected Advanced or Recurrent Malignancies [Protocol 09-012]	Wolchok, Jedd, MD, PhD
A Phase Ib Study of Panobinostat (LBH589) with Docetaxel and Prednisone in Patients with Hormone-Refractory Prostate Cancer [Protocol 07-163]	Rathkopf, Dana, MD, PhD
A Phase Ib Study of SGN-40 with Rituximab and Gemcitabine for the Treatment of Relapsed or Refractory Diffuse Large B-Cell Lymphoma [Protocol 08-078]	Moskowitz, Craig, MD
A Phase Ib Study of the Anti-VEGF Agent PTC299 in Patients with Advanced Cancer [Protocol 08-043]	Schwartz, Gary, MD
A Phase Ib/II Study of AMG 655 plus Modified FOLFOX6 and Bevacizumab for the Initial Treatment of Patients with Metastatic Colorectal Cancer [Protocol 07-161]	Saltz, Leonard, MD
A Phase Ib/IIa Study of AV-951 in Combination with Paclitaxel in Patients with Advanced or Metastatic Breast Cancer [Protocol 08-136]	Dickler, Maura, MD
A Phase Ib/IIa Study of AV-951 in Patients with Advanced Non-Small Cell Lung Cancer [Protocol 08-144]	Rizvi, Naiyer, MD
A Pilot Phase II Study of Targeted Radiotherapy with ¹³¹I-MIBG and Arsenic Trioxide in Patients with Resistant Neuroblastoma or Malignant Chromaffin Cell Tumors [Protocol 04-148]	Modak, Shakeel, MD
A Pilot Study of Docetaxel plus Vinorelbine as Adjuvant Chemotherapy for Patients with Resected Non-Small Cell Lung Cancer [Protocol 07-178]	Azzoli, Christopher, MD
A Pilot Study of Dose-Dense Adjuvant CMF (Cyclophosphamide, Methotrexate, and Fluorouracil) at 14-Day Intervals for Women with Early Breast Cancer [Protocol 07-133]	Drullinsky, Pamela, MD
A Pilot Study of High Dose-Rate Prostate Brachytherapy as Salvage Therapy for Locally Recurrent Prostate Cancer Previously Treated with External Beam Radiotherapy [Protocol 06-122]	Yamada, Yoshiya, MD
A Pilot Study of High-Dose Rate Brachytherapy as Definitive Management for Intermediate Risk Prostate Cancer [Protocol 07-120]	Yamada, Yoshiya, MD
A Pilot Study of Neoadjuvant Chemotherapy with Selective Use of Radiation for Locally Advanced Rectal Cancer [Protocol 07-021]	Saltz, Leonard, MD
A Pilot Study of Neoadjuvant FOLFOX plus Bevacizumab in Patients With Locally Advanced Colon Cancer [Protocol 08-162]	Saltz, Leonard, MD
A Pilot Study of Topical Imiquimod Therapy for the Treatment of Recurrent Extramammary Paget's Disease [Protocol 07-029]	Chi, Dennis, MD
A Pilot Trial Assessing the Safety and Immunogenicity of the GI-4000 Vaccine as Consolidation Therapy after Curative Treatment for Stage I-III Non-Small Cell Lung Cancers with K-ras Mutations [Protocol 07-149]	Azzoli, Christopher, MD
A Pilot Trial to Assess the Feasibility and Safety of G-CSF Mobilization of Hematopoietic Stem Cells in Patients with Beta-thalassemia Major [Protocol 08-030]	Boulad, Farid, MD
A Pivotal Study of ExAblate Treatment for the Relief of Pain in Patients with Metastatic Bone Tumors Who Are Not Candidates for Radiation Therapy [Protocol 08-131]	Maybody, Majid, MD
A Prospective Study Comparing Flexitouch^® Home Maintenance Therapy to Standard Home Maintenance Therapy for Lower Extremity Lymphedema Resulting from Treatment of a Gynecologic Cancer [Protocol 08-120]	Leitao, Mario, MD
A Prospective Study of Quality of Life in Patients Undergoing Pelvic Exenteration [Protocol 05-001]	Chi, Dennis, MD
A Prospective Study of Quality of Life in Patients with Invasive Bladder Cancer [Protocol 08-076]	Bochner, Bernard, MD
A Prospective, Longitudinal Study to Examine Time-Dependent Neurocognitive Changes in Patients with Breast Cancer Receiving Adjuvant Chemotherapy [Protocol 07-130]	Ahles, Tim, PhD
A Randomized Clinical Trial of Pelvic Irradiation with or without Cisplatin in Patients with Pelvic Recurrence of Endometrial Cancer [Protocol 08-112]	Leitao, Mario, MD
A Randomized Controlled Trial of Family-Focused Grief Therapy in Palliative Care and Bereavement [Protocol 05-120]	Kissane, David, MD
A Randomized Phase II Study of Hepatic Arterial Infusion in Combination with Intravenous Chemotherapy, with or without Bevacizumab in Patients with Resected Liver Metastases from Colorectal Cancer [Protocol 04-086]	Kemeny, Nancy, MD
A Randomized Phase II Study of Modified Docetaxel, Cisplatin, and Fluorouracil (mDCF) Treatment versus Conventional DCF with Growth Factor Support in Patients with Unresectable or Metastatic Gastric and Gastroesophageal Junction Cancer [Protocol 06-103]	Shah, Manish, MD
A Randomized Phase II Trial of Gemcitabine and Docetaxel with or without Bevacizumab in Leiomyosarcoma, Malignant Fibrous Histiocytoma, and Angiosarcoma [Protocol 09-015]	D'Adamo, David, MD
A Randomized Study Comparing Aflibercept versus Placebo in Patients Treated with Second-Line Docetaxel after Failure of One Platinum-Based Therapy for Locally Advanced or Metastatic Non-Small Cell Lung Cancer [Protocol 08-075]	Pietanza, M. Catherine, MD
A Randomized Study of MORAb-003 (Farletuzumab) Plus Paclitaxel in Patients with Platinum-Resistant or Refractory Relapsed Ovarian Cancer [Protocol 08-149]	Konner, Jason, MD
A Reduced Intensity Conditioning Regimen and the Transplantation of Unrelated Donor Umbilical Cord Blood in Patients with Acute Leukemia or Myelodysplasia [Protocol 08-087]	Barker, Juliet, MBBS
A Study Assessing the Use of AlloDerm in Two-Stage, Tissue Expander/Implant Breast Reconstruction [Protocol 08-024]	Disa, Joseph, MD
A Study Comparing Beads with Doxorubicin-Eluting Beads for Arterial Embolization of Hepatocellular Carcinoma [Protocol 07-099]	Brown, Karen, MD
A Study Evaluating the Effectiveness of Leuprolide for Enhancing Immune Function After Autologous Stem Cell Transplantation [Protocol 07-046]	Matasar, Matthew, MD
A Study of Brivanib in Patients with Advanced Tumors [Protocol 08-061]	Schwartz, Gary, MD
A Study of Group Psychotherapy Interventions for People with Cancer [Protocol 07-094]	Breitbart, William, MD
A Study of Pazopanib versus Sunitinib for the Treatment of Patients with Locally Advanced and/or Metastatic Renal Cell Carcinoma [Protocol 08-089]	Motzer, Robert, MD
A Study of SCH 717454 in Patients with Osteosarcoma or Ewing's Sarcoma That Has Relapsed After Standard Systemic Therapy [Protocol 08-134]	Meyers, Paul, MD
A Study of Salvage Chemotherapy Followed by Allogeneic Hematopoietic Stem Cell Transplant for the Treatment of High-Risk or Relapsed Hodgkin's Lymphoma [Protocol 07-147]	Perales, Miguel-Angel, MD
A Study of Temsirolimus and Sorafenib as Second-Line Therapy in Patients with Advanced Renal Cell Carcinoma that Has Grown Despite First-Line Sunitinib Therapy [Protocol 07-124]	Motzer, Robert, MD
A Study of [¹⁸F]-ML-10 as a PET Imaging Radiotracer for the Early Detection of Response of Brain Metastases of Solid Tumors to Radiation Therapy [Protocol 08-116]	Beal, Kathryn, MD
A Study to Characterize the Pharmacokinetics of Ipilimumab and Chemotherapy in Patients with Untreated Advanced Melanoma [Protocol 09-004]	Wolchok, Jedd, MD, PhD
A Study to Compare the Effectiveness of Pralatrexate versus Erlotinib in Patients with Progressive Stage IIIB/IV Non-Small Cell Lung Cancer After Cisplatin or Carboplatin [Protocol 08-115]	Azzoli, Christopher, MD
A Survey of Penile Injection Anxiety [Protocol 07-001]	Nelson, Christian, PhD
A Survey of Sleep Problems in Survivors of Early-Stage Breast Cancer [Protocol 06-071]	Passik, Steven, PhD
ALTE03N1: Key Adverse Events Following Childhood Cancer [Protocol 05-070]	Sklar, Charles, MD
Abdominal Obesity and Cardiovascular Risk Factors in Women Who Survived Leukemia Following Total Body Irradiation and Stem Cell Transplant [Protocol 07-092]	Oeffinger, Kevin, MD
Adherence to Comprehensive, Multi-Organ Screening Recommendations in Hereditary Non-Polyposis Colorectal Cancer (HNPCC) Patients [Protocol 04-144]	Hurley, Karen, PhD
Adjunctive Donepezil Therapy and Genetic Risk Factors of Cognitive Dysfunction in Brain Tumor Survivors [Protocol 04-122]	Correa, Denise, PhD
Adjuvant Paclitaxel and Trastuzumab for Node-Negative HER2-Positive Breast Cancer [Protocol 08-017]	Dang, Chau, MD
Adolescent and Young Adult Cancer Survivors: Identity Development [Protocol 09-001]	Ford, Jennifer, PhD
Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders [Protocol 00-069]	Offit, Kenneth, MD
Assessing Depression in a Geriatric Cancer Population [Protocol 06-100]	Nelson, Christian, PhD
Attitudes Towards Prophylactic Colectomy in HNPCC Patients [Protocol 04-127]	Hurley, Karen, PhD
BRCA1 Haploinsufficiency and Gene Expression [Protocol 04-045]	King, Tari, MD
Biaxin (Clarithromycin)-Based Antibiotic Therapy in Previously Untreated, Advanced Stage Indolent Lymphoma [Protocol 07-038]	Portlock, Carol, MD
Biomarkers of Molecular Risk in Smokers [Protocol 04-141]	Boyle, Jay, MD
Breast MRI as a Preoperative Tool for DCIS [Protocol 06-124]	Van Zee, Kimberly, MD
Carcinogen Metabolism, DNA Repair, Parental Exposures, and Retinoblastoma [Protocol 08-129]	Dunkel, Ira, MD
Chemotherapy Decisions and Outcomes in Women Age 65 or Older with Operable, Newly Diagnosed Breast Cancer [Protocol 04-030]	Lake, Diana, MD
Chemotherapy-Induced Changes in Cognition and DNA in Breast Cancer Survivors [Protocol 07-090]	Ahles, Tim, PhD
Classification of Acute Lymphoblastic Leukemia [Protocol 06-023]	Shukla, Neerav, MD
Clinical Outcomes in Hereditary Cancer [Protocol 06-004]	Robson, Mark, MD
Clinical Significance of Germline BRCA Mutations [Protocol 96-051]	Offit, Kenneth, MD
Clinical Study of McGhan Corporation-Style 410 Silicone-Filled Breast Implants [Protocol 06-024]	Disa, Joseph, MD
Collection of Saliva Samples for Genetic Epidemiology Studies of Cancer and Aging [Protocol 06-102]	Offit, Kenneth, MD
Combination of Targeted I¹³¹-3F8-Mediated Radioimmunotherapy and Bevacizumab in Patients with Relapsed or Refractory Neuroblastoma: A Phase I Study [Protocol 06-072]	Modak, Shakeel, MD
Contrast-Enhanced Breast MRI Evaluation of Patients Undergoing Neoadjuvant Treatment for Locally Advanced Breast Cancer [Protocol 03-019]	Morris, Elizabeth, MD
Cross-Sectional Study of Psychosexual Impact of Cancer-Related Infertility in Women: Third Party Reproductive Assistance [Protocol 06-110]	Carter, Jeanne, PhD
Cyclophosphamide, Fludarabine, and Total Body Irradiation Followed by the Transplantation of Unrelated Double-Unit Donor Umbilical Cord Blood Grafts for Patients with Hematological Malignancy [Protocol 06-014]	Barker, Juliet, MBBS
Decision Making Regarding Prophylactic Mastectomy and Oophorectomy in Women Seeking Genetic Testing for Inherited BRCA1 and BRCA2 Mutations [Protocol 03-001]	Hurley, Karen, PhD
Development and Validation of a New Patient-Reported Outcome Instrument on the Impact of Altered Facial Appearance Following Oncologic Head and Neck Resection and Reconstruction [Protocol 07-098]	Pusic, Andrea, MD, MHS
Early Onset and Familial Gastric Cancer Registry [Protocol 05-118]	Shah, Manish, MD
Effect of Imatinib on Bone Metabolism, Lipid Metabolism, and Thyroid Function in Patients with Chronic Myelogenous Leukemia or Gastrointestinal Stromal Tumors [Protocol 06-142]	Berman, Ellin, MD
Electronic Patient-Reported Outcomes from Home in Patients Recovering from Major Gynecologic Cancer Surgery: Measuring Symptoms and Quality of Life [Protocol 08-155]	Chi, Dennis, MD
Estrogen, Diet, Genetics & Endometrial Cancer [Protocol 01-119]	Olson, Sara, PhD
Evaluating the Response to Pre-operative Chemoradiotherapy for Rectal Cancer Using Three-Dimensional Transrectal Ultrasound (3-D TRUS) [Protocol 03-127]	Wong, Douglas, MD
Facilitating Parent Adaptation to Pediatric Transplant: The P-SCIP Trial [Protocol 08-062]	Bartell, Abraham, MD
Feasibility Study Using Fluoro-Misonidazole Positron Emission Tomography to Detect Hypoxia in Head and Neck Cancer Patients [Protocol 04-070]	Lee, Nancy, MD
Feasibility Study of STAR, an Internet-based System for Cancer Patients, to Self-report Toxicity Symptoms, Performance Status, and Quality of Life [Protocol 04-020]	Basch, Ethan, MD
Fludarabine-Based Conditioning for Allogeneic Marrow Transplantation from HLA-Compatible Unrelated Donors in Severe Aplastic Anemia [Protocol 06-056]	Castro-Malaspina, Hugo, MD
Functional Magnetic Resonance Imaging and Diffusion Tensor Imaging to Assess Tongue Function after Treatment for Tongue Cancer [Protocol 02-093]	Kraus, Dennis, MD
Functional Outcomes and Quality of Life in Patients Undergoing Surgery for Rectal Cancer [Protocol 06-151]	Temple, Larissa, MD
Functional Voice and Speech Outcomes Following Surgical Voice Restorations: A Comparison of Pharyngeal Reconstruction Approaches [Protocol 05-104]	Kraus, Dennis, MD
GLIOGENE: Genetic Epidemiology of Glioma International Consortium [Protocol 07-137]	Bernstein, Jonine, PhD
Genetic Variability as a Determinant of Chemotherapy Toxicity and Response in Pediatric Cancer and Bone Marrow Transplantation Patients [Protocol 03-123]	Meyers, Paul, MD
Genetic Variates of Response to Cisplatin/Vinblastine/Temozolomide Therapy in Patients with Metastatic Melanoma [Protocol 09-017]	Chapman, Paul, MD
Health Communication in Families [Protocol 03-088]	Hay, Jennifer, PhD
Health-Related Outcomes for Hodgkin's Disease Survivors [Protocol 06-140]	Trippett, Tanya, MD
Hereditary Colorectal Cancer Family Registry [Protocol 01-110]	Guillem, Jose, MD
High Intensity Focused Ultrasound for the Treatment of Low-Risk, Localized Prostate Cancer [Protocol 08-016]	Eastham, James, MD
Illness Related Distress in Women with Clinically Localized Cutaneous Melanoma [Protocol 08-096]	Brady, Mary, MD
Immunization of High-Risk Breast Cancer Patients with a Sialyl Lewis^a-Keyhole Limpet Hemocyanin Conjugate plus the Immunological Adjuvant QS-21 [Protocol 06-156]	Gilewski, Teresa, MD
Improving Functional Outcomes in Patients with Unilateral Vocal Cord Paralysis: Assessment of Adaptation Using Functional Magnetic Resonance Imaging [Protocol 05-036]	Kraus, Dennis, MD
Inamed Corporation-Style 410 Silicone-Filled Breast Implant Continued Assess Reconstruction/Revision Expansion (CARE) Clinical Study [Protocol 06-076]	Cordeiro, Peter, MD
Liposomal Muramyl Tripeptide Phosphatidyl Ethanolamine (L-MTP-PE): Compassionate Access for High-Risk Osteosarcoma [Protocol 08-021]	Meyers, Paul, MD
Longitudinal Assessment of Health-Related Quality of Life in Men with Localized Prostate Cancer [Protocol 02-042]	Scardino, Peter, MD
Lost to Cancer: Prolonged Grief in Young Bereaved Spouses and Partners [Protocol 08-100]	Roth, Andrew, MD
Measuring Patient Expectations for Breast Reconstruction [Protocol 07-024]	Pusic, Andrea, MD, MHS
Measuring Patient Satisfaction in Breast Surgery: Development and Validation of a Patient-Reported Outcomes Instrument [Protocol 05-058]	Pusic, Andrea, MD, MHS
Melanoma Survivors: Health Behaviors, Surveillance, Psychosocial Factors, and Family Concerns [Protocol 06-128]	Oliveria, Susan, ScD, MPH
Memorial Sloan-Kettering Cancer Center Pancreatic Tumor Registry [Protocol 02-102]	Kurtz, Robert, MD
Microvascular Reconstruction for Advanced-Stage Head and Neck Cancer Patients: A Prospective Analysis of Quality of Life and Symptom Relief [Protocol 07-150]	Pusic, Andrea, MD, MHS
Molecular Characterization of Neuroblastic Tumors and Clinical Outcome [Protocol 00-109]	Cheung, Nai-Kong, MD, PhD
Molecular Mechanisms of Clinical Resistance to Anti-HER2 Therapy Among Patients with HER2-Amplified Breast Cancer [Protocol 06-163]	Hudis, Clifford, MD
Multimodality Treatment for Patients with Resectable Non-Small Cell Lung Cancer (BEACON Study: BEvacizumab And Chemotherapy for Operable NSCLC) [Protocol 05-052]	Rizvi, Naiyer, MD
Neoadjuvant Hormonal Therapy in Combination with Vorinostat Followed by Radical Prostatectomy for Localized Prostate Cancer [Protocol 06-160]	Slovin, Susan, MD, PhD
Pain and Quality of Life in Cancer Survivors [Protocol 07-068]	Passik, Steven, PhD
Participation in the National Marrow Donor Program Registry [Protocol 90-091]	Kernan, Nancy, MD
Phase I Study of Aflibercept With or After Radiation Therapy and Temozolomide in Patients with Malignant Glioma [Protocol 08-106]	Lassman, Andrew, MD
Phase I Study of Alpharadin^TM in Patients with Hormone-Refractory Prostate Cancer and Skeletal Metastases [Protocol 08-058]	Morris, Michael, MD
Phase I Study of Anti-GD2 3F8 Antibody and Allogeneic Natural Killer Cells for High-Risk Neuroblastoma [Protocol 09-011]	Modak, Shakeel, MD
Phase I Study of MDX-1401 in Patients with CD30-Positive Refractory/Relapsed Hodgkin's Lymphoma [Protocol 07-169]	Horwitz, Steven, MD
Phase I Study of PF-02341066 in People with Advanced Cancer [Protocol 07-157]	Maki, Robert, MD
Phase I Study of Single Agent Perifosine for Recurrent Pediatric Solid Tumors [Protocol 08-091]	Becher, Oren, MD
Phase I Study of Weekly Nanoparticle Albumin-Bound Paclitaxel with Cetuximab and Intensity-Modulated Radiation Therapy in Patients with Locally Advanced Head and Neck Cancer [Protocol 08-084]	Fury, Matthew, MD, PhD
Phase I Study of Xenogeneic CD20 DNA Vaccination in Patients with B-cell Lymphoma [Protocol 07-100]	Palomba, M. Lia, MD
Phase II Prospective Clinical Trial of Vaccine Responses in Childhood Survivors of Cancer Who Had Chemotherapy [Protocol 07-088]	Small, Trudy, MD
Phase II Prospective Trial of Vaccine Responses Against Pneumococcus and Influenza in Adult Cancer Patients Age 65 and Older [Protocol 08-005]	Small, Trudy, MD
Phase II Study of CBP501, Pemetrexed, and Cisplatin in Chemotherapy-Naïve Patients with Malignant Pleural Mesothelioma [Protocol 08-082]	Krug, Lee, MD
Phase II Study of Docetaxel Plus Cetuximab and Concurrent Re-Irradiation (Intensity-Modulated Radiation Therapy) for Patients with Locoregionally Recurrent Head and Neck Cancer [Protocol 08-050]	Fury, Matthew, MD, PhD
Phase II Study of Nimotuzumab (TheraCIM^®) in Pediatric Patients with Recurrent Diffuse Intrinsic Pontine Glioma [Protocol 08-034]	Trippett, Tanya, MD
Phase II Study of Patupilone (EPO906) to Treat Recurrent or Progressive Brain Metastases in Patients with Non-Small Cell Lung Cancer [Protocol 05-085]	Omuro, Antonio, MD
Phase II Study of Sunitinib in Patients with Metastatic Non-Clear Cell Renal Cell Carcinoma [Protocol 07-019]	Kroog, Glenn, MD
Phase II Study of a Novel Capecitabine Dosing Schedule in Combination with Lapatinib in Patients with Trastuzumab-Refractory Metastatic Breast Cancer [Protocol 08-025]	Traina, Tiffany, MD
Phase II Toxicity Study Using Chemotherapy Followed By Intensity Modulated Radiation Therapy to the Pleura in Patients with Locally Advanced Unresectable Malignant Pleural Mesothelioma [Protocol 08-053]	Rosenzweig, Kenneth, MD
Phase II Trial of Paclitaxel, Ifosfamide, and Cisplatin in Patients with Previously Untreated Advanced Germ Cell Tumors [Protocol 07-044]	Feldman, Darren, MD
Phase III Study of Three Treatment Regimens in Patients with Previously Untreated Multiple Myeloma Who Are Not Candidates for High-Dose Chemotherapy and Autologous Stem Cell Transplantation [Protocol 08-018]	Hassoun, Hani, MD
Phase IIb/III Study of BIBW 2992 plus Best Supportive Care (BSC) versus Placebo plus BSC in Non-Small Cell Lung Cancer Patients Failing Erlotinib or Gefitinib [Protocol 08-056]	Miller, Vincent, MD
Physical Activity Intervention for Lung Cancer Survivors [Protocol 08-067]	Ostroff, Jamie, PhD
Pilot Evaluation of Radioimmunodetection of ¹²⁴Iodine-labeled Humanized A33 Antibody (¹²⁴I-huA33) in Patients with Colorectal Cancer [Protocol 03-124]	Larson, Steven, MD
Pilot Study of Molecular Imaging Using Positron Emission Tomography (PET) to Determine Protein and Gene Expression Signatures of Colonic Polyps [Protocol 07-114]	Gollub, Marc, MD
Pilot Study of Sulindac, a Pan-COX Inhibitor, in Oral Premalignant Lesions [Protocol 04-099]	Boyle, Jay, MD
Pilot Trial to Determine Toxicity and Antibody Responses with a Vaccine Containing GD2 Lactone and GD3 Lactone in Patients with Disease-Free Stage III or IV Melanoma [Protocol 06-086]	Chapman, Paul, MD
Prospective Evaluation of Quality of Life and Development of Measures in Patients with Cancer of the Oral Cavity [Protocol 04-137]	Kissane, David, MD
Prospective Phase II Study of R-CODOX-M/IVAC, including Central Nervous System Penetration and Intensive Intrathecal Prophylaxis, in HIV-associated Burkitt's and Atypical Burkitt's Lymphoma [Protocol 07-033]	Noy, Ariela, MD
Prospective Randomized Trial of Acute Normovolemic Hemodilution Compared to Standard Intraoperative Management in Patients Undergoing Major Hepatic Resection [Protocol 04-004]	Jarnagin, William, MD
Quality of Life Outcomes Following Treatment for Esophageal Cancer [Protocol 03-083]	Bains, Manjit, MD
Quality of Life and Pain Outcomes Following Video-Assisted Thoracic Surgery (VATS) Lobectomy versus Thoracotomy and Lobectomy [Protocol 05-006]	Park, Bernard, MD
Quantification of Sensation Following Postmastectomy Breast Reconstruction [Protocol 06-047]	Mehrara, Babak, MD
Radiotherapy Alone versus Chemotherapy Followed by Response-Based Radiotherapy for Newly Diagnosed Primary CNS Germinoma [Protocol 07-167]	Dunkel, Ira, MD
Radiotherapy Plus Sildenafil (Viagra) to Preserve Erectile Function Versus Radiotherapy Alone in Localized Prostate Cancer [Protocol 05-007]	Zelefsky, Michael, MD
Retinoblastoma Survivor Study: Assessment of General Health and Quality of Life [Protocol 08-019]	Dunkel, Ira, MD
Risk-Adapted Therapy for Patients With Untreated Low-Intermediate Risk, High-Intermediate Risk, or High Risk Diffuse Large B-Cell Lymphoma [Protocol 08-026]	Moskowitz, Craig, MD
Screening for Depression in Lung Cancer Patients [Protocol 06-038]	Passik, Steven, PhD
Sensory Morbidity Following Breast Surgery [Protocol 08-009]	Pusic, Andrea, MD, MHS
Serum Protein Profiling to Characterize Patient Risk in Men Undergoing Radical Prostatectomy [Protocol 04-132]	Eastham, James, MD
Structural Imaging and Cognitive Functions in Adult Stem Cell Transplant Recipients Treated with Radiation Therapy and Chemotherapy [Protocol 06-162]	Correa, Denise, PhD
Survey and Blood Sample Collection for Patients with Lung Cancer Who Never Smoked Cigarettes [Protocol 08-104]	Pao, William, MD, PhD
The Impact of Androgen Ablation Therapy on Cognitive Functioning and Functional Status in Men with Prostate Cancer Age 65 and Older [Protocol 06-084]	Nelson, Christian, PhD
The Use of Breathing Synchronized PET/CT Imaging in the Detection and Quantification of FDG Uptake in Lung Nodules [Protocol 04-025]	Schoder, Heiko, MD
Total Anorectal Reconstruction with the Acticon Neosphincter Prosthesis after Abdominoperineal Resection [Protocol 02-124]	Wong, Douglas, MD
Use of Breast MRI and Biomarker Studies to Characterize Tumor Response in Patients Receiving Neoadjuvant Treatment for Locally Advanced Breast Cancer [Protocol 02-086]	Montgomery, Leslie, MD
Vincristine, Dactinomycin, and Lower Doses of Cyclophosphamide in Patients with Newly Diagnosed Low-Risk Embryonal/Botryoid Rhabdomyosarcoma [Protocol 05-032]	Wexler, Leonard, MD

Site Map \| Index	Legal Disclaimer \| Privacy Practices \| Public Notices

©2009 Memorial Sloan-Kettering Cancer Center. 212-639-2000 1275 York Avenue New York, NY 10065.	PublicAffairs@mskcc.org